VECT-HORUS

company

About

VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain.

  • 11 - 50

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
€3.50M
Industries
Biopharma,Biotechnology,Health Care,Life Science
Founded date
Jan 1, 2005
Number Of Employee
11 - 50
Operating Status
Active

VECT-HORUS is a biotechnology company that develops peptide-based vectors facilitating the drug delivery or imaging agents into the brain, organs, and tumors. The vectors target receptors involved in “Receptor-Mediated Transport” (RMT, a physiological system for the transport into cells of endogenous substances by combining drugs or imaging agents to its vectors, VECT-HORUS allows them to cross biological barriers that restrict access to their target, notably the blood-brain barrier (BBB).

Founded in 2005 by Alexandre Tokay and Dr. Michel Khrestchatisky, the biotech company is based in Marseille, Marseille, Provence-Alpes-Cote d'Azur.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€3.50M
VECT-HORUS has raised a total of €3.50M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2018 Series Unknown €3.50M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
VECT-HORUS is funded by 3 investors. Financière Tuileries Co-Invest and SCR Provençale et Corse are the most recent investors.
Investor Name Lead Investor Funding Round
Financière Tuileries Co-Invest Series Unknown
SCR Provençale et Corse Series Unknown
CAAP Creation Series Unknown